Form 4: McKesson Corp Executive Thomas L Rodgers Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Executive Vice President of McKesson Corp, Thomas L Rodgers, reports acquisition and disposal of company stock related to performance stock units and tax obligations.

Summary

  • Thomas L Rodgers, EVP, Chief Strategy & BDO of McKesson Corp, reported transactions involving the company's common stock on May 20, 2025.
  • Rodgers acquired 3,664 shares of common stock upon the settlement of performance stock units (PSUs) at $0 per share.
  • He also disposed of 1,234 shares to cover taxes related to the PSU settlement at a price of $719.19 per share.
  • Following these transactions, Rodgers directly owns 4,974 shares of McKesson Corp common stock.
  • Additionally, Rodgers was granted 974 Restricted Stock Units (RSUs) which will vest in three equal installments on May 20, 2026, May 20, 2027, and May 20, 2028.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices and doesn't indicate any significant positive or negative developments for the company. The vesting of PSUs suggests the achievement of performance goals, which is mildly positive.

Positives

  • The vesting of performance stock units suggests the achievement of certain performance goals within McKesson Corp.

Future Outlook

The RSUs granted to Thomas L Rodgers will vest in three equal installments on May 20, 2026, May 20, 2027, and May 20, 2028, incentivizing continued performance.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often tied to performance-based compensation plans. This filing provides transparency into the compensation structure and equity ownership of McKesson's top executives.

Comparison to Industry Standards

  • Executive compensation packages in the healthcare industry often include a mix of salary, stock options, restricted stock units, and performance-based bonuses.
  • The vesting schedule of the RSUs (1/3 each year for three years) is a fairly standard practice to retain executives and align their interests with long-term shareholder value.
  • Comparing the total equity compensation of Thomas L Rodgers to peers at companies like Cardinal Health (CAH) and AmerisourceBergen (ABC) would provide a better understanding of McKesson's compensation practices relative to industry benchmarks.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
  • Employees may view the vesting of PSUs as a positive sign of company performance.

Key Dates

DateDescription
05/20/2025Date of stock transactions (PSU settlement and tax withholding) and RSU grant.
05/20/2026First vesting date for 1/3 of the granted RSUs.
05/20/2027Second vesting date for 1/3 of the granted RSUs.
05/20/2028Final vesting date for 1/3 of the granted RSUs.
05/22/2025Date of signature on the Form 4 filing.

Keywords

McKesson Corp, Thomas L Rodgers, Stock Transactions, Form 4, Performance Stock Units, Restricted Stock Units, Executive Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.